MedTrace Logo

Asian Multicenter Prospective Study of ctDNA Sequencing

NCT05099978 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 506

Last updated 2024-09-04

No results posted yet for this study

Summary

This study is a genetic analysis of aberrations in circulating tumor DNA (ctDNA) in patients in Asian countries. This study protocol is divided into parts describing several subanalyses that differ in terms of cancer types, analytical methods, participating countries, and participating institutions.

Conditions

Interventions

GENETIC

NGS analysis of ctDNA

Diagnostic Test: plasma circulating tumor DNA

Sponsors & Collaborators

  • National Cancer Center, Japan

    lead OTHER_GOV

Principal Investigators

  • Kan Yonemori, MD, PhD · Department of Medical Oncology, National Cancer Cancer Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05099978 on ClinicalTrials.gov